Bridget Barber is an Infectious Diseases Physician, Principal Research Fellow at Menzies School of Health Research, and Head of Clinical Research in the Clinical Tropical Medicine Group at QIMR-Berghofer. She completed her infectious diseases training in 2010, and during 2010 – 2013 undertook a PhD with Menzies School of Health Research which involved establishing a clinical research site in Sabah, Malaysia, and leading a prospective study to evaluate comparative epidemiological and clinical features of patients with knowlesi, falciparum and vivax malaria. With ACREME she will continue to study the burden of knowlesi malaria in Sabah as Malaysia approaches elimination of the human-only Plasmodium species, in addition to investigating comparative pathophysiological mechanisms of disease from severe falciparum, vivax and knowlesi malaria.Related Projects
Related Publications
- A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria
- An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples
- Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum
- Diagnostic accuracy and limit of detection of ten malaria parasite lactate dehydrogenase-based rapid tests for Plasmodium knowlesi and P. falciparum
- Diagnostic performance of a 5-plex malaria immunoassay in regions co-endemic for Plasmodium falciparum, P. vivax, P. knowlesi, P. malariae and P. ovale
- Effect of novel antimalarial ZY-19489 on Plasmodium falciparum viability in a volunteer infection study
- Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis
- Evaluation of a point-of-care haemozoin assay (Gazelle device) for rapid detection of Plasmodium knowlesi malaria
- Genomic Analysis of Plasmodium vivax in Southern Ethiopia Reveals Selective Pressures in Multiple Parasite Mechanisms
- No Association between the Plasmodium vivax crt-o MS334 or In9pvcrt Polymorphisms and Chloroquine Failure in a Pre-Elimination Clinical Cohort from Malaysia with a Large Clonal Expansion
- Positron emission tomography and magnetic resonance imaging of the brain in experimental human malaria, a prospective cohort study
- Quantification of parasite clearance in Plasmodium knowlesi infections
- Quantification of Tafenoquine and 5,6-Orthoquinone Tafenoquine by UHPLC-MS/MS in Blood, Plasma, and Urine, and Application to a Pharmacokinetic Study
- Safety, pharmacokinetics, and antimalarial activity of the novel triaminopyrimidine ZY-19489: a first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study, pilot food-effect study, and volunteer infection study
- The Effect of Regularly Dosed Acetaminophen vs No Acetaminophen on Renal Function in Plasmodium knowlesi Malaria (PACKNOW): A Randomized, Controlled Trial
- The efficacy of dihydroartemisininpiperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysis
- The haematological consequences of Plasmodium vivax malaria after chloroquine treatment with and without primaquine: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis
- Transmission Blocking Activity of Low-dose Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum
- Variability in white blood cell count during uncomplicated malaria and implications for parasite density estimation: a WorldWide Antimalarial Resistance Network individual patient data meta-analysis